We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.85 | 4.70 | 5.00 | 4.85 | 4.85 | 4.85 | 56,585 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.55 | 25.87M |
TIDMEDEN
RNS Number : 4957K
Eden Research plc
05 January 2021
05 January 2021
Eden Research Plc
("Eden" or "Company")
Green Economy Mark
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free encapsulation technology for use in crop protection, animal health and consumer products industries , is pleased to announce that it has received London Stock Exchange's Green Economy Mark.
The Green Economy Mark recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Its underlying methodology incorporates the Green Revenues data model developed and managed by FTSE Russell. Through its consistent application across London Stock Exchange markets and segments, the Green Economy Mark and Green Revenue tracking provides a detailed taxonomy on environmental goods, improving visibility to investors and other stakeholders interested in the global industrial transition to a green and low carbon economy.
Sean Smith, CEO of Eden Research, commented: "We are delighted to be the first company to receive London Stock Exchange's prestigious Green Economy Mark in 2021. As the UK's only listed AIM company focused on biopesticides for sustainable agriculture, being recognised with the Green Economy Mark clearly demonstrates our credentials to investors and other stakeholders, highlighting Eden's efforts to support the transition to a sustainable world. We continue to see a growing number of investors putting ESG and sustainability at the heart of their decision making process. This is a signi cant accreditation for Eden and we are honoured to be part of this esteemed group of companies and funds."
For further information contact:
Eden Research plc www.edenresearch.com Sean Smith Alex Abrey 01285 359 555 Cenkos Securities plc (Nominated advisor and broker) Giles Balleny / Cameron MacRitchie (corporate finance) Michael Johnson (sales) 020 7397 8900 Hawthorn Advisors (Financial PR) Lorna Cobbett / Victoria Ainsworth eden@hawthornadvisors.com
Notes to Editors:
Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden's Sustaine(R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally derived, plastic-free, biodegradable micro-spheres derived from yeast extract. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.
Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012. edenresearch.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEZLFBFFLXBBL
(END) Dow Jones Newswires
January 05, 2021 02:00 ET (07:00 GMT)
1 Year Eden Research Chart |
1 Month Eden Research Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions